NEW YORK (GenomeWeb News) – Glioblastoma tumors essentially hide mutant EGFR in response to therapies targeting those mutations, a new study appearing in Science reported today. Further, after drug treatment is stopped, those mutations reappear.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.
Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.
The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.
In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.